Article Sidebar
Published:
Mar 18, 2019Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Curcumin induces apoptosis in lung cancer cells via mitochondria-dependent signal pathways
Abstract
Purpose: To investigate the effect of curcumin on the growth and viability of lung cancer cells.
Methods: The viability of curcumin-treated A-427 and A-549 cells, and changes in their morphologies were assessed using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and phase-contrast microscopy, respectively. Flow cytometry and western blot assays were employed for the determination of apoptosis and changes in protein expressions, respectively.
Results: Curcumin treatment altered the morphologies of A-427 and A-549 lung cancer cells. The viability of A-427 cells was reduced to 89, 71, 49, 26 and 25 %, respectively, on treatment with 5, 10, 15, 20 and 25 μM curcumin, while the corresponding decreases in viability of A-549 cells treated with the same doses of curcumin were 91, 74, 53, 31 and 29 %, respectively. Treatment with 20 % curcumin resulted in 62.87 % apoptosis in A-549 lung cancer cells. Curcumin increased the proportion of cells in G0/G1 phase in a concentration-dependent manner, and increased the expressions of p21 and p-p53 proteins in A-427 cells, while the expressions of cyclin E and Cdc25c were decreased. Curcumin treatment also enhanced the expressions of Bax, cleavage-caspase-8 and PARP in A-549 cells.
Conclusion: Curcumin inhibits lung cancer growth by inducing apoptosis and cell cycle arrest. Thus, curcumin has a promising potential for the treatment of lung cancer.
Keywords: Curcumin, Lung cancer, Apoptosis, Viability, Intrinsic, Reactive oxygen species
